NCR3 and neuroblastoma: Despite the fact that Semeraro and colleges presented evidence regarding the clinical impact of NKp30 and its ligand B7-H6 [33] in patients with high risk neuroblastoma [34], no studies have clarified this association in the outcome of viral infections.